Featured Pharma Online Editorial

1. CDMO Live Europe 2026: Partnerships For An Uncertain World 7/27/2026

   112 pages of executive insight from CDMO Live Europe 2026: tariffs, geopolitics, supply resilience, AI in manufacturing, and why strategic partnerships remain aspirational for most.

2. Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report 7/27/2026

   Senior pharma leaders from Pfizer, Bayer, BioNTech and others debunk dual sourcing myths and reveal what separates strategic CDMO partnerships from transactional ones.

3. EMA's New Guideline For Synthetic Peptides: A More Explicit CMC Playbook For A Growing Therapeutic Class 6/23/2026

   The European Medicines Agency’s Guideline on the Development and Manufacture of Synthetic Peptides, adopted in Dec. 2025 and effective from June 1, 2026, is an important regulatory development for peptide manufacturers.

4. Can Molecular Glue Degraders Make The Undruggable Druggable? 6/12/2026

   Neomorph CEO Phil Chamberlain explains how molecular glue degraders could expand the druggable proteome and why the modality’s small-molecule profile may matter as much as its novel mechanism.

5. 6 Things You Need to Know from Life Sciences Future SW 4/16/2026

   For momentum in pharmaceutical research and development, consider taking a second look at Western Pennsylvania, where capital is flowing in, innovation is picking up and growth is expected.

6. New MIT Consortium Links Innovation With Real-World Biomanufacturing 3/6/2026

   In one area, the Initiative for New Manufacturing is exploring whether microfactories, championed by the EV industry, can help biopharma iterate facility design faster.

7. 9 Pharma Trends To Watch In 2026 2/27/2026

   What does 2026 ultimately hold for the industry? To explore that question, Lawrence Blatt, CEO of Aligos Therapeutics, sat down with me to share his perspective on the trends shaping the year ahead.

8. Rethinking Product Development Through Lipid-Based Formulations 2/24/2026

   Optimization of lipid-based drug formulation, when developed with the correct technology, can lead to major product performance enhancements that benefits patients.

9. A 2025 Pharma Look Back and Look Forward: Editor Style 1/7/2026

   Though I still have a great deal to learn about the pharmaceutical industry, I am surrounded by a warm and incredibly bright cast of editors that I gain knowledge from every day.

10. Is Charisma An API? 11/19/2025

    After nearly 20 years in the pharmaceutical industry, Samir Shah, director of regulatory CMC for medical products and combination products at AstraZeneca, knows how beneficial charisma can be for the pharmaceutical professional. That’s why he presented the topic at the 2025 RAPS Convergence.